THE POTENTIAL VALUE of heterologous anticharacterized for toxicity and antibody conlymphoid serum as an immunosuppressive tent, and rendered to globulin as fully de-I agent has been known for a number of years. scribed elsewhere (4). The test organs in the I However, the first reference to testing of canine experiments were the kidney and I antiserums for homograft protection was by liver. The clinical patients had renal ho- I Woodruff, who later published with Andermotransplantation. son (20, 21) detailed observations of the I effect of these agents used alone or in corn-I bination with thoracic duct drainage. SubCanine experiments. One hundred and sequent valuable studies have been con&my-four mongrel dogs weighing 10 to 25 tributed by Waksman, Gray (2), Monaco kilograms were immunized against hepatitis (9, 10) and their respective associates and by and distemper and used as homograft reJeejeebhoy, Nagaya and Sieker, and Levey cipients. Operations were performed under and Medawar (6, 7). The experimental sodium pentobarbital anesthesia combined model for the foregoing experiments conwith the tranquilizer phencyclidine hydrosisted of skin grafting in mice, rats, or guinea chloride. Renal transplants were accompigs which were treated with antiserums plished by transferring the donor kidney to raised in rabbits. Except for our own brief the contralateral recipient iliac fossa, with report (14) and those of Abaza, and Mitchell anastomoses of the renal artery to the proxiand their colleagues there are no published mal end of the cut common iliac artery, the accounts on the use of antilymphoid serum renal vein to the side of the common iliac I for the protection of whole organ homovein, and the ureter to the bladder. Bilateral recipient nephrectomy was always carried
I
The present study is a further evaluation out. Orthotopic hepatic transplants were I of the importance of this kind of immunoperformed as previously described (15) . Be-I suppressive therapy for the protection of fore and after both kinds of homotransplan-I whole organ homografts in dogs, as well tation, blood urea nitrogen, serum bilirubin, as an account of its subsequent application alkaline phosphatase, serum glutamic oxal-I in humans. Antiserums against the lymphoid acetic transarninase, serum glutarnic pyruvic I tissue of both species were raised in horses, transaminase, and complete hematologic I studies were obtained at frequent intervals. light microscopy. In a number of experiThe leukoagglutinating titer of the reconments, biopsies were taken at varying instituted injectate was 1 :512 to 1 :1,024. The tervals after transplantation and examined subcutaneous dose schedule was 0.2 to 0.5 both with light and electron microscopy. milliliter per kilogram per day. The effecAntilymphoid plasma.-The 3 kinds of tiveness of immunosuppression was evalantilymphoid agents were obtained from imuated both with renal and orthotopic liver munized horses as described previously (4). homotransplantation. The first was unabsorbed antilymphoid
For 25 kidney transplantations pretreatplasma with a leukoagglutinin titer of 1 :16 ment of 7 to 13 days was provided for 12, to 1 :256. The dose of 1 to 4 milliliters per and therapy was begun on the day of operakilogram was given intraperitoneally every tion in the other 13. In 4 of 9 dogs receiving 1 to 3 days for 5 to 30 days before renal holiver grafts therapy was started on the day motransplantation and by a similar schedule of transplantation, and the other 5 had 5 during the first 20 or 30 postoperative days. to 26 days of pretreatment. In the recipients After this time, the intervals between inof both kidney and liver homografts, therapy jections were increased to 4 to 30 days or was stopped from 35 to 60 days after transtherapy was stopped. The plasma was toxic.
plantation. Of 36 dogs entered into tlie experiment, 1 1 Another 4 dogs received renal homotransdied before operation. Twelve of the remainplantation after pretreatment for 60 days. ing 25 definitive test animals had thymNo postoperative therapy was given to these ectomy 7 to 20 days before institution of animals. plasma therapy.
Antilymphoid globulin and azathioprine. Antilymphoid serum. -The second prod--Crude globulin was given to 14 dogs, beuct tested was antilymphoid serum with a ginning on the day of operation. Postoperatiter of 1 :32 to 1 : 128. This was obtained from tively, 1 milligram per kilogram per day 4 of the same horses, but it was prepared azathioprine was added. from coagulated blood and partially abControl studies.-The survival of nonsorbed against 10 per cent dog red cell pack. treated control animals previously reported Six dogs received renal homotransplantation from our laboratory was 11.3 + 4.6 stanwith a comparable intraperitoneal dose dard deviation (SD) days after renal hoschedule as that d'escribed for plasma. In motransplantation (14) and 7.1 f 2.2 (SD) addition, 6 other animals received kidneys days after orthotopic liver transplantation with intraperitoneal antiserum therapy start-(1 5). New control animals were prepared for ing on the day of transplantation. the present study with 7 renal and 10 orThe same antilymphoid serum was given thotopic liver transplantations. The results intraperitoneally to 9recipientsoforthotopic
were not different from those in the older liver homografts, beginning 1 to 26 days series for which reason both old and new before operation. One of the pretreated dogs groups were combined for statistical comreceived no further therapy after transplanparison with the results using antilymphoid tation, but the others had additional posttherapy. operative injections.
Four other control animals were treated Antilymphoid globulin.-The third kind for 30 days with crude globulin prepared of antilymphoid agent tested was crude from the serum of nonimmunized horses. globulin which was precipitated from imThe dose of protein was the same, approximune horse serum with ammonium sul-mately 30 milligrams per kilogram per day, fate after absorption of the serum with dog as with the globulin from immunized horses. red cells, and in some instances with dog Renal homotransplantation was then perserum, kidney, and liver. Many ofthe batches formed, and the subcutaneous globulin adused were concentrated by lyophilization. ministration continued daily until death. Renal homotransplantation was perEight patients with terminal renal failure formed in 7 dogs treated only with 1 milliwere treated with immune globulin. In 7, gram per kilogram per day azathioprine. the horse globulin was given for 5 or 6 days Data comparison.-The various operain advance of renal homotransplantation tions were performed over a period of alas well as postoperatively. In the eighth pamost 1% years with variable periods of tient, pretreatment was for 35 days. After available follow-up. In order to avoid bias operation, injections were continued daily in the event of unusually long survival and to for 1 to 2 weeks, then every other day for allow comparison of series studied at dif-2 to 3 weeks, and finally reduced to twice ferent times, credit for survival of any ania week until the fourth month after which 1 ma1 was limited to 70 days.
injection per week was given. Two of these The variously tested antilymphoid subpatients had transthoracic thymectomy prior stances differed in their titer, degree of purito transplantation. All 8 kidneys were obfication, and extent of absorption with tistained from blood relatives. There were 2 sues or red cells from the lymphoid donor mothers and 6 siblings. The donor and respecies. Therefore, an effort was made to cipient ages ranged from 21 to 45 and from relate the results by means of a unit system 16 to 36 years respectively. which was based upon leukoagglutinating
In contrast to the animal experiments, titers of these different agents. If 1 milliliter horse globulin was never used as the sole of either horse plasma, horse serum, or immunosuppressive agent. Azathioprine was crude horse globulin had a titer of 1:128, started on the day of operation and conit was said to contain 128 units. With a titer of tinued thereafter in daily doses of 5.2 to 0.5 1 : 1,024, 1 milliliter was considered to con-milligram per kilogram per day. During the tain 1,024 units. It is recognized that such first month, prednisone was added if needed a unit nomenclature is arbitrary and that for control of rejection. After this time, when the therapeutic efficacy may not be directly the antilymphoid globulin therapy was berelated to the titer as the system implies.
ing reduced, prednisone was started in doses Clinical studies. Twelve patients have been of 0.3 to 0.67 milligram per kilogram per given intramuscular antihuman immune day for patients who had not had rejection.
globulin which was prepared from the serum Actinomycin C in intravenous doses of 400 of horses immunized with the lymph nodes, micrograms and local homograft irradiation thymuses, and spleens of fresh cadavers (4).
were used irregularly if and when rejection After absorption of the horse serum with occurred. human red cells and serum, precipitation
To evaluate the effect of the globulin therwith ammonium sulfate, and lyophilization, apy, comparisons were made with comthe reconstituted product had a leukoagparable patients treated in the past a t the glutinin titer of from 1 :8,192 to 1 : 16,384.
University of Colorado in whom survival of The single doses of 4 milliliters provided 450 at least 63 days had been attained. The to 2,100 units per kilogram. The protein control patients of intrafamilial homotranscontent was 7 to 9 grams per cent. The deplantations were divided into 3 groups of velopment of human antibodies against 25, 13, and 22 each. The first series of rehorse protein was monitored serially with cipients, treated in 1962 and 1963, had reprecipitin tests. The titers of hemagglutinins ceived azathioprine only until the onset of against sheep red blood cells were also fol-rejection at which time prednisone was lowed, and intradermal skin tests with 0.1 added. The second group received high milliliters injectate were performed every 2 dose steroid therapy from the day of operaweeks. The response to antilymphoid globtion onward in addition to azathioprine. ulin of nontransplanted uremic individuals The third group differed in that smaller is described elsewhere (4).
quantities of prednisone, usually 0.5 milli-gram per kilogram per day, were started on the day of operation. This steroid dose was increased only when required to treat rejection. In all 3 groups, attempts were later made to reduce the prednisone dosage as rapidly as possible. Since inclusion in the control groups was contingent upon survival for 63 days, unfavorable patients were automatically eliminated. Thus 7, 1, and 3 patients who were unsuccessfully treated with the respective protocols for less than this period were excluded. An additional patient in group 2 died on the last day but is included. Lymphocyte antigens were analyzed by Terasaki and his associates in the donors and recipients from the 3 control groups as well as the antilymphoid series. This information became available retrospectively in 21 of the 25 patients of group 1 and 10 of the 13 patients in group 2. I t was obtained prospectively for all patients of group 3 and of the antilymphoid series. In the last series, there were good, average, and poor matches in 3, 3, and 2 patients respectively. Statistical comparison performed by Terasaki revealed no significant differences in the quality of antigen compatibility among the donor-recipient combinations in 4 groups.
For each of the 3 control groups and for the antilymphoid series, the events in the first 63 postoperative days were compared by determining the average daily blood urea nitrogen, creatinine, creatinine clearance, white blood count, lymphocyte differential, lymphocyte count, azathioprine dose, and prednisone dose. From these data it could be determined if the function in the antilymphoid patients was as good as in the previous series, if this function had been achieved with greater or smaller doses of standard imrnunosuppressive agents, and if there were consistent differences in the peripheral white cell differential and total counts in the various groups.
Late homograft rejection.-Three patients had received maternal, cadaveric, and maternal kidneys respectively, 1 1, 7, and 5 months previously. In each, there was deterioration of renal function when the prednisone dose was reduced below 1.3, 1.7, and 1 milligram per kilogram per day, in the first, second, and third patients. In each instance, 4 milliliters of antilymphoid globulin with a titer of 1:4,096 to 1:16,384 were instituted every other day or twice a week, and the prednisone dose was then attenuated.
Secondary cadaveric homotransplantation.-A 23 year old girl with removal of a failed homograft 31 months after transplantation from a nonrelated living donor received 2 cadaveric kidneys 5 and 8 weeks later while being treated with antilymphoid globulin, azathioprine, and prednisone. The first cadaveric homograft which began to excrete urine after a week was removed as an emergency 2 days later because of acute renal vein thrombosis. She had a cardiac arrest during bronchoscopy and died 8 days after placement of the second cadaveric kidney which did not function. Since evaluation of therapy was impossible under these circumstances, this patient will not be discussed further.
RESULTS
Canine experiments. Antilymphoid plasma.
-The 25 dogs treated before and after renal homotransplantation with doses of 64 to 512 units immune plasma had a survival of 28. During the early postoperative period when injections were given every 1 to 3 days, the animals lost weight. They usually became profoundly anemic, a complication apparently attributable at least in part to the high hemagglutinin titers in the immune plasma (4). Later when therapy was either reduced transplantation lived 38 days, the others all or stopped, renal failure developed, usually died in less than 15 days. Mean survival was rather slowly, in the longer surviving animals 12.8 + 12.5 (SD) days, a value which was not significantly better than nontreated conAntilymphoid serum. -Weight loss and trols. anemia were also observed with intraperiAfter orthotopic liver transplantation 5,4, toneal antilymphoid serum administrations, 3, and 2 of the 9 animals lived for more than but there were no preoperative deaths. serum over a 26 day preoperative period. After liver transplants tion, no further therapy was given. A definite lymphopenic effect was not produced (Fig. 2) . The second animal, which had pretreatment for 1 month, received postoperative serum treatment for only 20 days. After stopping therapy, there was a striking lyrnphocytosis (Fig. 3) , despite which overt rejection has not occurred.
Antilymphoid globulin.-The dogs received 100 to 500 units of globulin subcutaneously. Gradual weight loss was not uncommon. A few batches of globulin caused anemia which developed slowly over a period of several weeks, but this was an unusual complication.
The 12 dogs treated both before and for 2 months after renal homotransplantation had a postoperative survival of 22.9 f 23 (SD) days, a statistically significant (p < 0.02) prolongation of survival. Five, 4, 3, and 3 animals lived for more than 15, 20, 30, and 50 days respectively. In contrast, the 13 dogs treated only after operation had a reduced survival of 14.3 f 7 (SD) days, a prolongation which was nevertheless statistically significant (p < 0.05). This group had 4, 2, 1, and 0 living animals after 15, 20, 30, and 50 days. The slow but progressive late rejection in the animals treated with globulin (Fig. 4 ) was similar to that described earlier in recipients treated with immune plasma or serum.
The 4 dogs which received kidneys after 60 days of pretreatment but which were not treated after operation all died after 9 to 15 days. Survival was 12 f 3 (SD) days. There was no statistically significant difference from nontreated controls.
The immunosuppressive effect after orthotopic liver transplantation was more consistent (p < 0.01). With limitation of credit to a maximum of 70 days for any dog, the mean survival was 36 f 30 (SD) days. Five, 5, 4, and 4 dogs lived for more than 15, 20, 30, and 50 days respectively. The longest survival, in an animal which is still alive, has been 120 days. The 5 dogs which received therapy both before and after operation did not fare better than the 4 treated only afterward.
As described earlier with immune plasma or serum, the production or maintenance of lymphopenia was not a prerequisite for po- Data comparison.-The foregoing data were used to ask several questions of potential clinical importance. To do this, smaller groups were combined into larger series and the significance of differences in results were subjected to the Student t test.
Is pretreatment valuable? The 18 animals which received either antilymphoid serum or globulin both before and after transplan- Although the results with the two combined agents were better than those obtained when antilymphoid globulin was used alone in a comparable dose schedule, the difference was not statistically significant (p < 0.2). Similarly, the increased survival with the two combined agents in comparison with that using azathioprine alone was not statistically significant.
Is success easier to attain with liver than with kidney transplantation? Survival in the 18 liver experiments involving antilymphoid serum or globulin was significantly better half of the recipients in each kind of transwas a reduction in the degree of cellular inplantation received therapy both before and filtration, the number of cells possessing pyafter operation, and the other half were only roninophilic cytoplasm, and the incidence of treated following operation. mitoses in those homografts fromdogs treated Pathologic studies.-Ninety-nine of the with both low doses of azathioprine and antirenal homografts were examined histologilymphoid globulin. Two of these 14 kidneys cally. In dogs treated with antilymphoid subhad no evidence of rejection, the only ones stances the features of rejection were not difcompletely spared in the entire study. ferent from those described by Porter and Similarly, in the 17 hepatic homografts his associates after immunosuppression with studied either from autopsy or biopsy speciother antirejection agents. These included mens, the findings were comparable to those infiltration with mononuclear cells of which previously reported in dogs protected with 20 to 80 per cent had pyroninophilic cytoazathioprine (15) . Animals dying before 3 plasm. Platelet thrombi and intimal fibrous weeks had centrizonal and usually midzonal thickening of interlobular and arcuate arnecrosis, infiltration of mononuclear cells teries were common. Fibrinoid necrosis of around the portal tracts and central veins, arteriolar and arterial walls was present in and centrilobular cholestasis. The 6 homohalf the specimens and glomerular capillary grafts examined after 3 weeks had variable basement membrane thickening was found centrilobular hepatocyte atrophy or reticulin in 27 per cent. Vascular and glomerular condensation, or even later fibrosis and prochanges were rare in either the controls or liferation of bile ductules in the portal tracts. treated dogs with short survival. The only Five of these 6 livers contained mononuclear clear difference in the various test groups cells but in 2 of these the numbers were low. In all, pyroninophilic cells were sparse. In hepatotoxic agent (15) , but conceivably the several of these livers, active rejection aphorse protein could have contributed by the peared to have ceased in contrast to the findsynergistic mechanism described by Paroings in the homografts of the longest surviv-netto and Popper.
ing animals after renal homotransplantation Clinical studies. New patients.-All 8 rewhen the histologic appearance suggested cipients are alive with excellent renal functhat none of these kidneys was being tolertion from 9% to 14 weeks after transplantaated chronically.
tion. Their courses during the fist 63 days The effect of the antilymphoid products of convalescence are compared to those of on the lymphoid tissue, kidneys, and other the 3 earlier groups in Figures 5 and 8 . recipient organs has been described (4).
From 1962 to 1966 a trend to conservaThis included myocardial necrosis and tism with the use of azathioprine was noted. necrotizing coronary arteritis which were
The mean daily dose of 1.92 milligrams per also present but in lower incidence in the kilogram in the fourth series differed significontrolanimals. Dogs whichhad renal homocantly from the means of the first and second transplantation under antilymphoid therapy (p < 0.01) but not of the third group. A alone had hepatic cholestasis or centrizonal significant lineardownward trend (p < 0.01) necrosis in an incidence of 10 and 4 per cent was present in all. respectively. When azathioprine was also
In contrast, the average daily dose of given, these figures rose to 77 and 61 per steroids in the 3 control groups remained cent. This latter finding was probably largely quite stable despite the effort to change the due to the azathioprine which is a known therapeutic protocol. However, the patients in the antilymphoid globulin series received not made during the first 63 days (Fig. 6 ) in greatly reduced quantities of prednisone. 4 of the 8 patients. In 3 others, a mild rejecThe average daily dose was 0.72 milligram tion crisis was easily reversed. Only 1 reper kilogram, a statistically significant reduccipient had a secondary rise in blood urea tion (p < 0.05) compared to 1.58 milligrams nitrogen to over 100 milligrams per cent, reper kilogram in the pooled control series. quiring protracted high dose steroid therapy Renal function in all 4 groups was ana- (Fig. 7) . These results are compared in Table  lyzed to determine if the drug reduction de-I with those obtained in the 3 retrospective scribed had been at the expense of an incontrol series. Only in group 2, in which creased homograft injury. When the pooled massive steroid therapy was used from the values of blood urea nitrogen, plasma creatibeginning, was there a similar number of nine, and creatinine clearance from the 3 patients who escaped early postoperative recontrol series were compared with those of jection. The comparison with group 3 is the fourth, there was no significant-difference particularly important.-The latter patients in any of the 3 tested variables.
all had prospective antigen-typing studies As would be suspected from these data, and were treated from the beginning with difficulties of the antilymphoid series with 30 to 60 milligrams per kilogram per day rejection were not serious. This diagnosis was prednisone, despite which early rejection oc- Blood changes.-These are shown in Figure 8 . With succeeding series there was a distinct linear rise in the average daily total white cell count, probably as the result of the increasingly cautious use of azathioprine described earlier. Due to the variability of the white cell counts, the differences between various pairs of groups were statistically nonsignificant. The per cent of lymphocytes in the peripheral blood was approximately the same in all 4 groups. The average total lymphocyte counts ranged from 1,380 to 1,606 per cubic millimeter, the highest values being from the patients receiving antilymphoid globulin (Fig. 8) , but the differences were not significant.
Late homograft rejection.-The clinical courses in these 3 patients during the iirst 10 to 13 weeks of antilymphoid globulin Group 4 (antilymp hoid). . . . . . .
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The reduced number of rejections in group2 waa evidently due to high dose prophylactic therapy with predniaane. therapy are summarized in Table 11 . The 2 patients who had received kidneys from related donors had stabilization of renal function despite very drastic decreases in steroid therapy. In both instances, previous dose adjustments of considerably lesser magnitude had resulted in deterioration of function (Fig. 9) . The pIasma creatinine and the creatinine clearance were not significantly altered in one patient, and in the other there was slight improvement. There were striking faIls in the blood urea nitrogen, which were probably at least partially due to decreased protein catabolism secondary to the steroid withdrawal.
The third patient, who had a failing cadaveric homograft, also had a decline in blood urea nitrogen. Nevertheless, there was a measurable further loss of creatinine clearance with a rise in plasma creatinine during the 13 weeks of steroid withdrawal (Table  11) .
In all 3 patients, the institution of horse globulin reduced the lymphocyte fraction of the differential count but, because the white count was allowed to increase with adjustments of azathioprine dose, the absolute lymphocyte counts were relatively unchanged.
Evidence of serum toxicity. -Fever as well as tenderness at the injection site was seen not only of erythema but also of induration. The antihorse-protein precipitin titers rose Four of the 11 patients had a systemic reslightly in all 11 patients. In 10 the maxiaction other than fever. In 1, hives develmum titer did not exceed 1 : 16 and in the oped. Another became hypertensive for alother it reached 1:32. Five patients had a most an hour. Immediately after injection, T precipitin titer which at first rose and then in the other 2 patients hypotension developed later declined despite continuation of injecwhich lasted for 5 and 30 minutes and which tions (Fig. 7) .
was accompanied by air hunger. All 4 pal Hemagglutinin titers against sheep red tients recovered without specific therapy and blood cells rose in 8 of 10 patients tested, in each has subsequently received many more 6 instances to 1 :32 or less, and in the other injections without incident. 2 to 1 :256 and-1512. Secondary declines All patients had-quantitative studies of were documented in 4 patients.
urine protein excretion because of recent Skin tests, which were obtained in 10 pa-demonstration in dogs that antilymphoid tients, showed an increased reaction in 7. globulin can cause renal lesions (4). The 3 This was usually evident in both the 30 minpatients treated late already had proteinuria before instituting globulin therapy and could little histologic evidence of continuing injury. not therefore be accurately evaluated. None
The incompleteness of immunosuppresof the 8 patients treated with globulin from sion with antilymphoid serum was also evithe outset has proteinuria judged by standent in the studies of Abaza and his assodard laboratory urinalysis. Quantitative ciates with canine renal homotransplantaanalysis of 24 hour specimens revealed protion. Using daily intravenous therapy, they tein excretion of less than 400 milligrams were able to prolong homograft function in per day in each after a follow-up of 2 to 3 6 of 8 dogs, in 4 of which uremia eventually months.
developed. Maximum survival was 79 days after transplantation and 58 days after re-DISCUSSION moval of the recipient's own kidneys at a Two general conclusions with immediate second stage operation. Using sheep antidogclinical implications seem justified from the lymphoid serum intravenously, Mitchell and information now available concerning antihis colleagues reported only 1 of 8 dogs with dog-lymphoid products. First, there is an imsurvival of more than 22 days, but that aniportant difference in the response to injecmal lived for 10 months after simultaneous tions of globulin prepared from the serum of homotransplantation and bilateral nephrecimmunized as compared to nonimmunized tomy. The consistency of success has thus horses. In the former, development of antibeen less than that reported in inbred rodent bodies to the foreign protein is markedly reexperiments by several previous investigators tarded as measured by the simple and cliniwho employed a skin graft test system. cally practical precipitin test (4), presumably
The foregoing information imposed cerbecause of the immunosuppressive qualities tain restrictions upon the way in which horse of the injectate. The risk of serum sickness antihuman-lymphoid globulin could be clinis undoubtedly thereby reduced, as the earically evaluated. It was clear that it had to lier rodent studies of Gray and associates (3) be used as an adjuvant rather than as the and Levey and Medawar predicted. It is not primary immunosuppressive drug. For this eliminated, however, since low increases in reason, it became important to know of the precipitin titer were often seen in dogs, an physiologic interaction between the antilymobservation which may explain the appearphoid substances and the more conventional ance of glomerular lesions after chronic therimmunosuppressive agents. This was a parapy in a significant number of nontransticularly important question since an earlier planted animals as discussed elsewhere (4). hypothesis of Levey and Medawar (6), subSecondly, although the capacity of the sequently disproved by the same investigapresently available heterologous antilymtors (7), held that the immunosuppressive phoid agents to mitigage rejection of the properties of antilymphoid serum were due canine kidney or liver was easily and unto binding of the heterologous antibodies to equivocally demonstrable in the present recipient lymphocytes thereby "blindfoldseries of transplantations, its effect in an ining" and functionally emasculating them. dividual experiment was unpredictable and Such a possibility implied that the action of weaker than that known to be obtainable antilymphoid substances was dependent with optimal doses of azathioprine. Not only upon astabile lymphoid population, and that was there a higher incidence of uncontrolled the superimposition of agents which caused early rejection but also, even after weeks or a rapid turnover of stem cells might cancel months, the renal homografts all had evithe effect. dence of active rejection. I t is of interest that
The canine experiments with antilyrnmore consistent early protection of hepatic phoid globulin plus azathioprine were therehomografts was observed, and that in some fore critical. I t was found that the limited examined after several months there was but definite prolongation of survival, whicli could be achieved with suboptimal therapy performance of thymectomy in some of the using either agent, was slightly increased patients herein reported may not, therefore, when the 2 were employed together. Al-have been justified. though this improvement was not statistiAnother detail worth additional comment cally significant, the really important obser-concerns the proper timing for adrninistravation was that survival was not made worse.
tion of the antilymphoid substances. Careful Moreover, the extent of histologic damage studies by Levey and Medawar (6) indicated was less in those homografts from dogs prothat 1 or 2 intraperitoneal injections were vided with combination therapy. most effective if given 2 days or more after There is evidence that antilymphoid sub-skin grafting and that pretreatment was of stances can be used to complement the efficonsiderably less value. Working with a simcacy of other immunosuppressive measures.
ilar mouse system but with therapy for longer The studies which are most relevant to the periods, Monaco and his colleagues (9) found clinical protocol finally decided upon were pretreatment to be distinctively advanmade by Levey and Medawar (7). They tageous, a conclusion supported by our cashowed a profoundly synergistic effect of nine studies. There is probably no real inadrenal corticosteroids with antilymphoid consistency in these results. Monaco's experserum, an observation not dissimilar to that iments and those herein reported were not of Woodruff and Anderson (20) who com-designed to determine the most important bined antilymphoid serum with thoracicduct time to give a single or a limited number of drainage in mice. Levey and Medawar (7) injections, but instead to determine if treathave also demonstrated that total body h ament for a number of days before as well as diation and immune serum treatment could after transplantation was superior to that be used together with benefit, providing the started just before or at the time of operation. roentgenotherapy was given before exposure I t is important to make this distinction, since to the antigen. When irradiation was used pretreatment did appear to be of value in late, well established skin homografts in the canine experiments and was accordingly serum-treated mice were rejected within a made part of the protocol used for patients. few days, long before the expected time.
There is evidence that the clinical regimen The influence of thymectomy upon the efdeveloped as a result of these various confectiveness of antilymphoid serum or globusiderations has been a t least of short term lin therapy is more controversial. Monaco value. The 8 recipients in the test series did and his associates (1 0) and Jeejeebhoy, using not have unusually complete antigen matches rabbit antiserums in mice and rats respecwith their donors and did not appear to tively, reported far better results when the enjoy other advantages over previously thymus had been excised. This could not be treated patients. The 8 patients are well from confirmed in our canine studies, nor in those 9% to 14 weeks postoperatively. In each of of Levey and Medawar (7) whose mouse exthe preceding control series there was a 15 periments closely resembled those of Monaco to 28 per cent mortality rate during the same and his associates and of Jeejeebhoy. The period. The quantities of azathioprine and observed, this possibility has not yet been previously. After institution of globulin therexcluded. I t was principally because of this apy in the latter patients, steroid doses were consideration that 4 of the 8 patients in the reduced. In 2 of the 3 patients, renal funcseries of new patients were eventually treated tion stabilized or improved in the ensuing 10 with low dose steroid therapy even though to 13 weeks, but in the third there has been the clinical diagnosis of homograft rejection further deterioration. had not been made.
The experimental nature of the clinical trial has been stressed in light of the un-SUMMARY known risk of serious toxicity from the injecPlasma, serum, or globulin were prepared tions of horse protein. This morbidity can from the blood of horses which had been imbe completely assessed only with further obmunized with canine lymphoid tissues. The servation and by study of homograft bioprespective agents which were rendered prosies in those patients now under treatment. gressively less toxic by appropriate absorpWider clinical trial is not recommended until tion and purification procedures were adminthis information has been obtained. istered by the intraperitoneal or subcutaneous route to dogs which received either renal
